Business
Twist Bioscience to Host Virtual Biopharma Analyst & Investor Event on October 23, 2020
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of
About this update from Twist Bioscience Corporation
[{"type":"text","content":" SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--\nTwist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will host a Twist Biopharma Analyst & Investor Event on Friday, October 23, 2020. The event is scheduled to take place from 11:00 a.m. – 1:00 p.m. ET in a virtual format.\n\nThe event will include an overview of Twist Biopharma and its unique approach to antibody discovery facilitated by its precisely synthetized “Library of Libraries” and antibody optimization solution. Twist Biopharma enables its partners to apply next generation drug development to some of the world’s most intractable health challenges.\n\nThe program will also feature a series of presentations by three Twist Biopharma customers:\n\n\nTakeda Pharmaceutical Company\nRobert Mabry, Ph.D., Head of Global Biologics Research\n\n\n\nInvetx\nJürgen Horn, Ph.D., Founder and Chief Executive Officer\n\n\n\nNeogene Therapeutics\nCarsten Linnemann, Ph.D., President and Chief Executive Officer\n\n\nThe presentations will be followed by a Q&A session.\n\nThe call and accompanying slides will be webcast live on the company's website at https://investors.twistbioscience.com/events-and-presentations/events. To listen to the conference call live, please dial (888) 317-6003 (domestic) or (412) 317-6061 (international) and reference conference ID number 3930359.\n\nA replay of the conference call will be accessible approximately one hour after its completion through November 6, 2020 by dialing (877) 344-7529 (domestic) or (412) 317-0088 (international) and referencing replay access code 10148526. A webcast of the call will also be archived for 90 days under the Investor Relations section of the company's website at https://investors.twistbioscience.com/events-and-presentations/events.\n\nAbout Twist Biopharma\n\nBy leveraging its unique ability to manufacture DNA at scale, Twist Biopharma can construct proprietary antibody libraries precisely designed to match sequences that occur in the human body. This Library of Libraries gives Twist Biopharma partners an integral and unbiased resource for antibody therapeutic discovery and optimization. This precise and rational approach to library fabrication combined with sophisticated bioinformatics and sof...